Regeneron, a fully integrated biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of serious medical conditions including cancer, gout, and retinal and other diseases, will use the new facilities for its research and development laboratories, clinical development staff, corporate headquarters and administrative offices. With the two new buildings, Regeneron now occupies approximately 390,000 square feet in four buildings on the 116 acre Landmark campus. Regeneron, which had just four employees when it opened its research laboratories at The Landmark at Eastview in 1989, now has over 1,000 employees. Regeneron's full-scale manufacturing facility is in Rensselaer, New York.
In his comments at the ribbon cutting, Mr. Griffin said, "Regeneron has been a model partner for BioMed throughout our association. Their long history of scientific advancements in discovering drug candidates for treatment of serious conditions is a template for success in life science research and development. We look forward to many more years of supporting Regeneron's real estate needs in Westchester County."
The completion of this new facility is the culmination of a successful economic development effort involving the Empire State Development Corporation, the Westchester County Industrial Development Agency and the Town of Greenburgh. Regeneron and BioMed broke ground on the two new build-to-suit buildings, comprising approximately 230,000 square feet, in April 2007. William A. Berry & Son, Inc. of Danvers, Massachusetts, was the construction manager for the project.
|SOURCE BioMed Realty Trust, Inc.; Regeneron Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved